APN

COM:ASPENPHARMA

Aspen Pharmacare

  • Stock

Last Close

17,025.00

22/11 15:04

Market Cap

1.03B

Beta: -

Volume Today

1.21M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
revenue
29.52B
-
36.13B
22.40%
35.60B
1.46%
41.20B
15.73%
42.60B
3.39%
38.87B
8.74%
38.65B
0.58%
37.77B
2.28%
38.61B
2.22%
40.71B
5.45%
44.71B
9.82%
cost of revenue
15.79B
-
18.87B
19.50%
17.70B
6.21%
21.30B
20.34%
20.99B
1.45%
19.17B
8.66%
19.31B
0.73%
19.98B
3.43%
20.30B
1.62%
22.30B
9.86%
25.25B
13.23%
gross profit
13.72B
-
17.25B
25.74%
17.90B
3.74%
19.90B
11.17%
21.61B
8.57%
19.70B
8.83%
19.33B
1.85%
17.79B
7.99%
18.31B
2.91%
18.41B
0.56%
19.45B
5.68%
selling and marketing expenses
4.40B
-
5.61B
27.56%
6B
6.87%
4.10B
31.67%
4.05B
1.15%
3.52B
13.15%
3.43B
2.50%
3.08B
10.20%
2.92B
5.42%
2.92B
0.24%
3.43B
17.39%
general and administrative expenses
1.65B
-
2.82B
70.50%
2.60B
7.72%
1.40B
46.15%
1.77B
26.14%
1.65B
6.51%
1.60B
3.21%
1.84B
15.33%
1.48B
19.64%
1.68B
13.23%
1.63B
2.56%
selling general and administrative expenses
6.05B
-
8.43B
39.28%
8.60B
1.99%
5.50B
36.05%
5.82B
5.80%
5.17B
11.14%
5.03B
2.73%
4.92B
2.09%
4.40B
10.74%
4.60B
4.62%
5.06B
10.11%
research and development expenses
211M
-
195M
7.58%
260M
33.33%
433M
66.54%
other expenses
243.30M
-
372.40M
53.06%
300M
19.44%
6.10B
1,933.33%
5.21B
14.56%
5.16B
0.98%
5.34B
3.45%
3.67B
31.22%
5.07B
38.13%
cost and expenses
22.09B
-
27.68B
25.29%
26.60B
3.89%
32.90B
23.68%
32.02B
2.67%
29.51B
7.86%
29.68B
0.60%
28.57B
3.74%
29.77B
4.18%
31.77B
6.71%
35.80B
12.71%
operating expenses
6.30B
-
8.80B
39.82%
8.90B
1.09%
11.60B
30.34%
11.03B
4.91%
10.33B
6.34%
10.37B
0.36%
8.60B
17.09%
9.47B
10.13%
9.46B
0.03%
10.55B
11.47%
interest expense
1.43B
-
2.01B
40.60%
2B
0.34%
2.20B
10%
2.29B
4.18%
2.33B
1.75%
1.58B
32.33%
1.21B
23.64%
765M
36.51%
1.32B
73.07%
2.23B
68.20%
ebitda
7.87B
-
9.59B
21.79%
9.30B
2.97%
9.70B
4.30%
12.29B
26.73%
11B
10.52%
10.68B
2.91%
9.85B
7.78%
10.71B
8.69%
10.57B
1.24%
11.83B
11.94%
operating income
7.42B
-
8.45B
13.81%
9B
6.51%
8.30B
7.78%
9.24B
11.29%
4.81B
47.94%
7.06B
46.81%
7.07B
0.17%
8.67B
22.61%
7.82B
9.79%
7.00B
10.53%
depreciation and amortization
361.10M
-
1.04B
187.82%
1.20B
15.46%
1.30B
8.33%
1.37B
5.54%
1.27B
7.14%
1.60B
25.82%
1.65B
3.12%
1.71B
3.63%
1.79B
4.38%
1.97B
10.35%
total other income expenses net
-1.07B
-
-1.91B
78.97%
-2.90B
51.68%
-2.10B
27.59%
-1.84B
12.33%
-6.96B
278.33%
-3.85B
44.78%
-2.12B
44.93%
-642M
69.69%
-1.27B
97.35%
-1.28B
1.34%
income before tax
6.36B
-
6.54B
2.86%
6.10B
6.70%
6.20B
1.64%
7.40B
19.29%
2.77B
62.53%
5.60B
102.17%
5.99B
6.91%
8.13B
35.82%
6.55B
19.41%
5.71B
12.83%
income tax expense
1.35B
-
1.34B
0.92%
1.80B
34.47%
1.10B
38.89%
1.39B
25.91%
774M
44.12%
991M
28.04%
1.19B
20.18%
1.65B
38.20%
1.33B
19.38%
1.31B
1.28%
net income
5.01B
-
5.20B
3.87%
4.30B
17.33%
5.10B
18.60%
6.01B
17.84%
6.46B
7.54%
4.66B
27.84%
4.81B
3.04%
6.49B
35.00%
5.23B
19.42%
4.40B
15.76%
weighted average shs out
456.12M
-
456.30M
0.04%
456.40M
0.02%
456.40M
0%
456.40M
0%
456.50M
0.02%
456.50M
0%
456.50M
0%
453M
0.77%
444.22M
1.94%
444.32M
0.02%
weighted average shs out dil
456.22M
-
456.50M
0.06%
456.50M
0%
456.40M
0.02%
456.40M
0%
456.50M
0.02%
456.50M
0%
456.50M
0%
453M
0.77%
444.20M
1.94%
444.30M
0.02%
eps
10.98
-
11.40
3.83%
9.45
17.11%
11.17
18.20%
13.17
17.91%
4.64
64.77%
10.64
129.31%
9.66
9.21%
14.32
48.24%
11.77
17.81%
9.91
15.80%
epsdiluted
10.98
-
11.40
3.83%
9.45
17.11%
11.17
18.20%
13.17
17.91%
4.64
64.77%
10.64
129.31%
9.66
9.21%
14.32
48.24%
11.77
17.81%
9.91
15.80%

All numbers in (except ratios and percentages)